Can you give an overview of Truveta and the key milestones the company has achieved in recent years?

Truveta was founded in September 2020 with the vision of saving lives with data. Health systems from across the country are self-organized to share de-identified data to empower researchers to find cures faster, speed up clinical trials, advance patient care and outcomes, and address health equity. The pandemic brought this unmet need to my attention, and we started building a company that can greatly impact the healthcare and life sciences industry by structuring and de-identifying data collected during patient care so it can be used by everyone who needs it to innovate. This data has been locked in the past, but now, with the latest cloud technologies and the power of AI, we can take this large amount of unstructured data and make it useful for the industry to develop therapies and ultimately better patient care.

How can the industry leverage Truveta Studio?

Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19, and Boston Scientific is studying peripheral artery disease (PAD). Because Truveta Studio provides the most complete, highest quality, representative data on US public health, Pfizer and Boston Scientific can study patient care and outcomes with the timeliest data available. Our solution brings data to people's fingertips so they can understand how to treat patients, how outcomes differ among different patient populations, identify potential patients for clinical trials, and accelerate precision medicine with deep clinical data as well as outside factors such as income, education, transportation access, allowing more personalized care than ever before. We are saving lives by making data transparent and accessible to all, enabling answers to complex research questions quickly.

Can you speak to Truveta Prose and the trend toward expressing clinical concepts in a computable manner?

We saw a need to capture medical concepts, such as being fully vaccinated against COVID-19, and express them in such a way that they can inform health professionals. Truveta Prose is the first language to express computable medical concepts combining events from a patient’s longitudinal history, including diagnoses, labs, procedures, medications, vaccinations, devices, or any concept found within a clinical note. Using Truveta Prose, a researcher can quickly combine a set of definitions in a logical sequence to further refine the population they want to study.Prose enables unprecedented transparency in how medical concepts are computed in a study, to help earn trust in the conclusions of that study.

How does Truveta determine which health partners to work with?

At the core, Truveta is looking for partners that share our values and understand that their de-identified data can be used to improve patient care and outcomes. Health systems are providing care daily, and this daily data can be de-identified so that it cannot be traced back to the specific individual. Health system members share rich clinical data – with full diagnoses, vital signs, lab tests, clinical notes, and images – with Truveta daily and that data is de-identified and then structured and made accessible for ethical clinical research. We compensate the health systems when their de-identified data is used by others, encouraging them to become a member of Truveta.

What will be the key trends driving tech in the life sciences space in 2023 and beyond?

I believe augmentation in human decision-making is inevitable - using data and analytics to assist humans in making the right decisions. Furthermore, daily complete de-identified datasets can have a profound impact in helping the life science industry find cures faster and can enable every clinician anywhere to be an expert so they can diagnose patients more quickly and recommend the best treatment. I think that at some point someday we will see families having access to this data so they can make the most informed decisions about their care. This solution will be empowering for the innovators in the life sciences space trying to best take care of their patients.

What are Truveta’s goals for 2023?

Aligned with our vision of saving lives with data, we want to empower as many researchers as possible with the most complete health data and fast analytics tools to advance patient care and research. We look forward to partnering with companies throughout the health tech, life sciences, and health provider space over the coming year.